Intraocular inflammation is one of the more relevant complications of Behçet's disease (BD),
which tends to respond poorly to different medications. The ocular histopathologic changes …

Uveitis is one of the most common causes of vision loss and blindness worldwide. Local
and/or systemic immunosuppression is often required to treat ocular inflammation in …

Introduction: The efficacy of anti-TNFα agents has been recently evaluated in many studies
in Behçet's disease (BD), particularly in ocular and life-threatening manifestations such as …

Objective Vasculitis are a very heterogenous group of systemic autoimmune diseases,
affecting large vessels (LVV), small vessels or presenting as a multisystemic variable vessel …

Objective: The objective of this study was to investigate the effectiveness and safety of
interferon (IFN) α2a as an add-on treatment for refractory Behçet's uveitis (BU). Methods: In …

Objective. To assess the efficacy of monoclonal anti-tumour necrosis factor (TNF)-α agents
in patients with anterior uveitis (AU) in terms of decrease of recurrences, variation of visual …

Objective. To describe the epidemiology of non-infectious uveitis (NIU) in two tertiary referral
rheumatology units in Central and Southern Italy. Methods. Two hundred and seventyeight …

Behcet's disease (BD) is a chronic multi-systemic disease characterized by relapsing-
remitting oral ulcers, genital ulcers, ocular inflammatory involvements, and numerous other …

Purpose To evaluate the efficacy and safety of adalimumab (ADA, Humira®) for treatment of
non-infectious uveitis (NIU) refractory to conventional medications. Methods Anti-tumor …

Purpose: To evaluate the effectiveness and the systemic corticosteroid sparing effect of a
single intravitreal dexamethasone (DEX) implant in patients with chronic noninfectious …